Furthermore, the tremendous increase in the rate of MIF secretion as observed in breast cancer cells following stimulation with rMIF suggests that TAM-derived MIF could trigger MIF secretion from breast cancer cells, thus igniting a local MIF amplification loop. Here, MIF is linked to breast carcinoma.